These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 3901237
1. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Khan SR, Hackett RL. Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237 [Abstract] [Full Text] [Related]
2. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats]. Kawamura J, Nonomura M, Okada Y, Yoshida O, Takashima M, Itokawa Y. Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444 [Abstract] [Full Text] [Related]
3. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, Schröder FH. Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009 [Abstract] [Full Text] [Related]
4. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3]. Okada Y, Kawamura J, Nonomura M, Kuo YJ, Yoshida O. Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734 [Abstract] [Full Text] [Related]
5. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. Tsujihata M, Miyake O, Yoshimura K, Kakimoto KI, Takahara S, Okuyama A. J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758 [Abstract] [Full Text] [Related]
6. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Yamaguchi S, Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS. Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958 [Abstract] [Full Text] [Related]
7. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. Thamilselvan S, Menon M. BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133 [Abstract] [Full Text] [Related]
8. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers. Srinivasan S, Kalaiselvi P, Sakthivel R, Pragasam V, Muthu V, Varalakshmi P. Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589 [Abstract] [Full Text] [Related]
15. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H. J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302 [Abstract] [Full Text] [Related]
17. Credentials of Spirulina diet on stability and flux related properties on the biomineralization process during oxalate mediated renal calcification in rats. Farooq SM, Ebrahim AS, Asokan D, Sakthivel R, Savitha S, Rajesh NG, Varalakshmi P. Clin Nutr; 2005 Dec; 24(6):932-42. PubMed ID: 16084629 [Abstract] [Full Text] [Related]
19. Role of sex hormones in experimental calcium oxalate nephrolithiasis. Fan J, Chandhoke PS, Grampsas SA. J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S376-80. PubMed ID: 10541267 [Abstract] [Full Text] [Related]